Arrhythmia Disorders News

In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, rivaroxaban was associated with higher rates of major bleeding compared with low-dose aspirin, researchers reported.

The benefit of direct oral anticoagulants on stroke risk in patients with prior intracerebral hemorrhage and atrial fibrillation was partially offset by increased risk for future hemorrhage risk, a speaker reported.

Regardless of country-level income classification, medications for the secondary prevention of CVD remains underutilized and patients likely remain undertreated, researcher reported.

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications consumed more than 80% of Medicare Part D spending, researchers reported.

Patients with EGFR-mutated non-small cell lung cancer treated with osimertinib experienced more cancer therapy-related cardiac events than those treated with other EGFR tyrosine kinase inhibitors.

The American Heart Association has issued the 2025 update to its annual heart disease and stroke statistics report, detailing recent trends in CV-related morbidity and mortality.

Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top developments in thrombosis and coronary disease from 2024.

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March 29-31 in Chicago and online.

After the COVID-19 pandemic, the incidence rate of postural orthostatic tachycardia syndrome increased significantly, according to new data published in the European Heart Journal – Quality of Care and Clinical Outcomes.